Found: 19
Select item for more details and to access through your institution.
Fatal neutropenic enterocolitis associated with docetaxel use: A review of cases reported to the United States Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 923, doi. 10.1177/1078155219879494
- By:
- Publication type:
- Article
Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory Perspectives.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 11, p. 843
- By:
- Publication type:
- Article
Follicular dendritic cell sarcoma of the neck: Case report and review of current diagnostic and management strategies.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Follicular dendritic cell sarcoma of the neck: Case report and review of current diagnostic and management strategies.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 2, p. 235, doi. 10.1007/s10549-015-3673-z
- By:
- Publication type:
- Article
Methodology for Good Machine Learning with Multi‐Omics Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 745, doi. 10.1002/cpt.3105
- By:
- Publication type:
- Article
US Food and Drug Administration regulatory updates in neuro-oncology.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 375, doi. 10.1007/s11060-021-03789-5
- By:
- Publication type:
- Article
The Development of the Oncology Center of Excellence Patient-Friendly Language Glossary of Oncology Clinical Trial Terms.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 379, doi. 10.1093/oncolo/oyad034
- By:
- Publication type:
- Article
Systematic Review of PD‐1/PD‐L1 Inhibitors in Oncology: From Personalized Medicine to Public Health.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1786, doi. 10.1002/onco.13887
- By:
- Publication type:
- Article
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e164, doi. 10.1002/onco.13551
- By:
- Publication type:
- Article
Patient‐Friendly Language to Facilitate Treatment Choice for Patients with Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1011, doi. 10.1634/theoncologist.2018-0761
- By:
- Publication type:
- Article
Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action.
- Published in:
- Oncologist, 2018, v. 23, n. 8, p. 874, doi. 10.1634/theoncologist.2018-0157
- By:
- Publication type:
- Article
Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature.
- Published in:
- Vascular Medicine, 2021, v. 26, n. 5, p. 526, doi. 10.1177/1358863X211006470
- By:
- Publication type:
- Article
RE: Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1534, doi. 10.1093/jnci/djae158
- By:
- Publication type:
- Article
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 7, p. 1043, doi. 10.1093/jnci/djae066
- By:
- Publication type:
- Article
Inflammatory Breast Cancer: Yet Another Risk of the Obesity Epidemic?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 18, p. 1340, doi. 10.1093/jnci/djt236
- By:
- Publication type:
- Article
Response: Re: Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 9, p. 718, doi. 10.1093/jnci/djs166
- By:
- Publication type:
- Article
Why Do Phase III Clinical Trials in Oncology Fail so Often?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 23, p. 1738, doi. 10.1093/jnci/djr386
- By:
- Publication type:
- Article